(Q37992520)
Statements
1 reference
Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials? (English)
1 reference
Patrick G Morris
1 reference
1 July 2012
1 reference
1 reference
23
1 reference
6
1 reference
579-583
1 reference
Identifiers
1 reference
1 reference